You are viewing the site in preview mode
Skip to main content
| |
CSE (n = 41)
|
non-CSE (n = 60)
|
P value
|
|---|
|
Age(yr)
|
70
|
68
|
n.s.
|
|
Gender
|
|
Male
|
12(29%)
|
44(73%)
| |
|
Female
|
29(71%)
|
16(27%)
| |
|
Height(cm)
|
162
|
164
|
n.s.
|
|
Weight(kg)
|
64
|
65.5
|
n.s.
|
|
BMI(kg/m2)
|
25
|
23.9
|
n.s.
|
|
Side
| | |
n.s.
|
|
Left
|
18(44%)
|
25(42%)
| |
|
Right
|
23(56%)
|
35(58%)
| |
|
Charlson comorbidity index
| | |
n.s.
|
|
0-1
|
28(68%)
|
42(70%)
| |
|
>1
|
13(32%)
|
18(30%)
| |
|
Tumor size(mm)
|
34
|
23
|
<0.05
|
|
Clinical T stage
| | |
<0.05
|
|
T1a
|
25(61%)
|
55(92%)
| |
|
T1b
|
16(39%)
|
5(8%)
| |
|
Ureteral catheter placement
|
29(71%)
|
5(8%)
|
<0.05
|
|
Operation time(min)
|
183
|
154
|
<0.05
|
|
Consol time(min)
|
130
|
98.5
|
<0.05
|
|
Ischemic time(mim)
|
23
|
12
|
<0.05
|
|
Postoperative urine leakage
|
5(12%)
|
0
|
<0.05
|
|
Discharge(day)
|
9
|
7
|
<0.05
|
